Clinical Trials Logo

Warfarin clinical trials

View clinical trials related to Warfarin.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05942365 Completed - Clinical trials for Drug Drug Interaction

A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam

Start date: June 25, 2023
Phase: Phase 1
Study type: Interventional

This study is a single-center, open label phase I clinical study to characterize the DDIs potential of ZSP1273 With Warfarin and Midazolam in Chinese healthy participants. This study also aims to evaluate the safety and tolerability of ZSP1273 in the presence of Warfarin and Midazolam.

NCT ID: NCT05715541 Completed - Mobile Applications Clinical Trials

Inr Tracking Coumadin Use With Phone App

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This study aims to compare the INR values of the patients followed by face-to-face and telephone applications.

NCT ID: NCT03125668 Completed - Quality of Life Clinical Trials

Impact of Telephone Follow-up in Patient's Health-related Quality of Life That Use Warfarin

Start date: October 1, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to test an educational program with telephone follow-up to improve health-related quality of life (HRQoL), treatment adherence, and reduce anxiety and depression symptoms in patients who are starting oral anticoagulants (OA).

NCT ID: NCT00830570 Completed - Clinical trials for Venous Thromboembolism

The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings

MHSMayoWarf1
Start date: July 2007
Phase: N/A
Study type: Observational

The purpose of this quasi-experiment study, which could also be classified as a prospective observational intervention study, is to assess the impact of cytochrome P450 2C9 (CYP 2C9) and vitamin K epoxide reductase complex, subunit 1 (VKORC1) testing within a primary patient care setting.

NCT ID: NCT00735189 Completed - Warfarin Clinical Trials

Does Anticoagulant Control Change Following Referral Back to the Primary Care Physician?

Start date: November 2007
Phase: Phase 4
Study type: Interventional

Warfarin is a medication typically referred to as a blood thinner and is used to prevent the formation of blood clots, and hence prevent life-threatening events such as strokes and clots on the lungs (known as pulmonary emboli). This therapy is only safe and effective if the degree of blood thinning is kept within a narrow window - if the blood is "too thick" clots may form but if the blood is "too thin" the risk of bleeding increases. Complicating the control of warfarin is that different people require different amounts of it to have an appropriate degree of blood thinning, and once this amount is determined for a patient, it may be changed by factors that are encountered on a daily basis (i.e., diet, acute and chronic diseases, alcohol, medications, etc.). As such, regular monitoring is necessary to confer the benefits of this medication. Our Anticoagulation Management Service (AMS) has demonstrated really good control of blood thinning therapy by working with patients to inform them of the rationale for this medicine, the factors having the ability to impact its control, and encouraging the patient to be involved in their care (via provision of tools to document test results, one-on-one education and access to our program at any time with questions, etc.) Currently, our AMS has to limit the volume of patients seen due to resource limitations. As such, it is imperative that we investigate alternate strategies to manage these patients. Paramount, however, is that any long-term strategy must not confer inferior control of warfarin. The purpose of this study is to determine if the impact of AMS Care is sustained following the transfer of anticoagulation management to the family doctor. Operationally, the results of this study will guide future management of patients. If control of warfarin therapy declines with family doctor management, alternate strategies, such as patient self-management, will need to be investigated in a larger scale trial.

NCT ID: NCT00287313 Completed - Anticoagulants Clinical Trials

Daily Vitamin K in Patients on Warfarin With Unstable INRs

Start date: October 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if daily Vitamin K supplementation stabilizes INRs in patients taking warfarin with a history of frequent dose changes or variable INRs.